These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17258648)

  • 1. MRI and stroke: why has it taken so long?
    Donnan GA; Dewey HM; Davis SM
    Lancet; 2007 Jan; 369(9558):252-4. PubMed ID: 17258648
    [No Abstract]   [Full Text] [Related]  

  • 2. Imaging-guided extension of the time window: ready for application in experienced stroke centers?
    Röther J
    Stroke; 2003 Feb; 34(2):575-83. PubMed ID: 12577994
    [No Abstract]   [Full Text] [Related]  

  • 3. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 4. Feasibility and logistics of MRI before thrombolytic treatment.
    Sølling C; Ashkanian M; Hjort N; Gyldensted C; Andersen G; Østergaard L
    Acta Neurol Scand; 2009 Sep; 120(3):143-9. PubMed ID: 19133866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke awareness: signs often go unrecognized. Getting medical aid in under three hours is crucial to survival.
    Duke Med Health News; 2008 Jan; 14(1):5. PubMed ID: 18290280
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of MRI in the identification and treatment of early ischemic stroke lesions.
    O'Rourke F; Akhtar N; Emery D; Shuaib A
    CMAJ; 2004 Feb; 170(3):335-6. PubMed ID: 14757667
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail?
    Levine SR
    J Neurol Sci; 2004 Oct; 225(1-2):1-2. PubMed ID: 15465078
    [No Abstract]   [Full Text] [Related]  

  • 8. Expectations for tPA is pathway to litigation.
    ED Manag; 2011 Feb; 23(2):18-9. PubMed ID: 21400969
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
    Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P
    J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging helps identify who benefits from stroke intervention.
    Yuh WT; Taoka T; Ueda T; Chaloupka JC
    Diagn Imaging (San Franc); 1999 Dec; 21(12):77-82. PubMed ID: 10724845
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of a stroke alert protocol in the emergency department: a pilot study.
    Hoegerl C; Goldstein FJ; Sartorius J
    J Am Osteopath Assoc; 2011 Jan; 111(1):21-7. PubMed ID: 21258013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When every second counts. Cutting-edge hospitals are leveraging telestroke programs so neurologists can intervene when a stroke hits.
    Hagland M
    Healthc Inform; 2009 Dec; 26(12):31-3. PubMed ID: 20052882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis in patients with stroke and marked clinical fluctuations.
    Calleja S; Rodríguez S; Lahoz CH
    Arch Neurol; 2009 Mar; 66(3):416-8. PubMed ID: 19273766
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved door-to-needle times and neurologic outcomes when IV tissue plasminogen activator is administered by emergency physicians with advanced neuroscience training.
    Greenberg K; Maxwell CR; Moore KD; D'Ambrosio M; Liebman K; Veznedaroglu E; Sanfillippo G; Diaz C; Binning MJ
    Am J Emerg Med; 2015 Feb; 33(2):234-7. PubMed ID: 25498530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical acute stroke evaluation.
    Lutsep HL
    Neuroimaging Clin N Am; 1999 Aug; 9(3):401-9. PubMed ID: 10433634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicine. Stroke--tPA and the clinic.
    Marler JR; Goldstein LB
    Science; 2003 Sep; 301(5640):1677. PubMed ID: 14500967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria.
    Huang P; Khor GT; Chen CH; Lin RT; Liu CK
    Acad Emerg Med; 2011 Mar; 18(3):273-8. PubMed ID: 21401790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-month experience of acute stroke thrombolysis in Christchurch, New Zealand: emergency department screening and acute stroke service treatment.
    Fink J
    N Z Med J; 2005 May; 118(1214):U1430. PubMed ID: 15886726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing acute stroke and preventing secondary stroke.
    Massaro LM
    Adv NPs PAs; 2012 Jun; 3(6):16-21; quiz 22. PubMed ID: 22852233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.